Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
Sign Up to like & getrecommendations! Published in 2021 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-021-00848-x
Abstract: To date, there is no FDA-approved chemoprevention approach for tobacco-related HNSCC. Effective chemoprevention approaches validated in sufficiently powered randomized trials are needed to reduce the incidence and improve survival. In this review, we recap the… read more here.
Keywords: tobacco related; chemoprevention; chemoprevention precision; immunoprevention ... See more keywords